Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
Shah, Nirav Niranjan, Szabo, Aniko, Rajguru, Saurabh, Devata, Sumana, Howard, Mitch, Pereira, Deepa, Endres, Mariah, Longo, Walter L., Hamadani, Mehdi, Fenske, Timothy S., Fletcher, Christopher David
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Is autologous transplantation (autoHCT) in relapsed diffuse large B-cell lymphoma (DLBCL) patients achieving only a PET/CT positive partial remission (PR) appropriate in the CAR-T cell era?
Shah, Nirav Niranjan, Ahn, Kwang Woo, Litovich, Carlos, Fenske, Timothy, Hamadani, Mehdi
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Long-term safety with ≥12 months of pirtobrutinib in relapsed/refractory (R/R) B-cell malignancies
Coombs, Catherine Callaghan, Shah, Nirav Niranjan, Jurczak, Wojciech, Woyach, Jennifer Ann, Cheah, Chan, Patel, Krish, Maddocks, Kami J., Wang, Yucai, Muehlenbein, Catherine E., Wang, Chunxiao, Abhyankar, Sarang, Tsai, Donald Edward, Eyre, Toby A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
High complete response rate with TNB-486 in relapsed/refractory follicular lymphoma: Interim results from an ongoing phase 1 study
Nair, Ranjit, Jacobs, Ryan, Cho, Seok-Goo, Devata, Sumana, Gaballa, Sameh, Yoon, Dok Hyun, Stevens, Don A., Kim, Jin Seok, Shah, Nirav Niranjan, Brennan, Denise Marie, Law, Jason, Chen, Rob, Forcina, Alessandra, Buelow, Ben, Hou, Jing-Zhou
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort
Bowers, Jackson, Anna, Jacob, Bair, Steven Michael, Annunzio, Kaitlin, Epperla, Narendranath, Joy Pullukkara, Jerrin, Gaballa, Sameh, Spinner, Michael, Li, Shuning, Messmer, Marcus, Nguyen, Joseph, Ayers, Emily C., Wagner, Charlotte Burton, Hu, Boyu, Di, Mengyang, Huntington, Scott F., Furqan, Fateeha, Shah, Nirav Niranjan, Chen, Christina, Svoboda, Jakub
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Lisocabtagene maraleucel (liso-cel) in R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Primary analysis of TRANSCEND CLL 004
Siddiqi, Tanya, Maloney, David G., Kenderian, Saad, Brander, Danielle M., Dorritie, Kathleen Anne, Soumerai, Jacob, Riedell, Peter A., Shah, Nirav Niranjan, Nath, Rajneesh, Fakhri, Bita, Stephens, Deborah Marie, Ma, Shuo, Feldman, Tatyana A, Solomon, Scott R., Schuster, Stephen J., Perna, Serena K., Ou, San-San, Papp, Eniko, Chen, Yizhe, Wierda, William G.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment
Shah, Nirav Niranjan, Jurczak, Wojciech, Zinzani, Pier Luigi, Eyre, Toby A., Cheah, Chan, Ujjani, Chaitra Shankar, Izutsu, Koji, Ma, Shuo, Flinn, Ian W., Alencar, Alvaro Jose, Lewis, David John, Patel, Krish, Maddocks, Kami J., Wang, Yucai, Munir, Talha, Zelenetz, Andrew David, Balbas, Minna, Tsai, Donald E, Wang, Chunxiao, Wang, Michael
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
BRUIN MCL-321: A phase 3, open-label, randomized study of pirtobrutinib versus investigator choice of BTK inhibitor in patients with previously treated, BTK inhibitor naïve mantle cell lymphoma
Wang, Michael, Eyre, Toby A., Shah, Nirav Niranjan, Le Gouill, Steven, Dreyling, Martin H., Vandenberghe, Elisabeth, Wang, Yucai, Cheah, Chan, Song, Yuqin, Gandhi, Mitul, Chay, Christopher H., Sharman, Jeff Porter, Andorsky, David Jacob, Ruppert, Amy S., Duann, Chi-Wei, Muthig, Valerie A., Ito, Rodrigo, Jurczak, Wojciech
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma
Shah, Nirav Niranjan, Zhu, Fenlu, Schneider, Dina, Taylor, Carolyn, Krueger, Winfried, Worden, Andrew, Longo, Walter L., Hamadani, Mehdi, Fenske, Timothy, Johnson, Bryon, Dropulic, Boro, Orentas, Rimas, Hari, Parameswaran
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Allogeneic stem cell transplant (AHCT) in the eighth decade: Age is just a number
Narra, Ravi Kishore, Chhabra, Saurabh, Narayana, Swapna, Shah, Nirav Niranjan, Hamadani, Mehdi, Szabo, Aniko, Pasquini, Marcelo C., Hari, Parameswaran
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Evaluation and identification of protocols for safe and efficacious institutional administration of intravenous immune globulin in hypogammaglobulinemia associated with chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple myeloma
Feinsilber, Doron, McCoy, Cole, Hari, Parameswaran, Foy, Patrick C., Narra, Ravi, Fenske, Timothy S, Shah, Nirav Niranjan, Michaelis, Laura Christian, Kollu, Vidya, Mears, Katrina Angela, Osinski, Kristin, Froggatt, Nancy, Atallah, Ehab L., Dhakal, Binod
Published in Journal of clinical oncology (20.10.2018)
Published in Journal of clinical oncology (20.10.2018)
Get full text
Journal Article
A phase 1 open-label, safety, pharmacokinetic, and preliminary efficacy study of STRO-001, an anti-CD74 antibody drug conjugate, in patients with advanced B-cell malignancies
Krishnan, Amrita Y., Shah, Nina, Spira, Alexander I., Kaufman, Jonathan L., Niesvizky, Ruben, Shah, Nirav Niranjan, Burke, John M., Popplewell, Leslie, Martin, Thomas G., Cheung, Julee, Matheny, Shannon L., Leonard, John Paul, Molina, Arturo
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies
Thompson, Meghan, Nabhan, Chadi, Cheson, Bruce D., Allan, John Nathan, Barr, Paul M., Skarbnik, Alan P., Jacobs, Ryan, Ujjani, Chaitra Shankar, Furman, Richard R., Schuster, Stephen J., Shah, Nirav Niranjan, Pagel, John M., Hill, Brian Thomas, Brander, Danielle M., Shadman, Mazyar, Zent, Clive, Lamanna, Nicole, Tuncer, Hande H., Lansigan, Frederick, Mato, Anthony R.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A phase I trial of lenalidomide maintenance after autologous stem cell transplant (ASCT) in patients with high-risk relapsed/refractory lymphomas
Svoboda, Jakub, Strelec, Lauren, Shah, Nirav Niranjan, Chong, Elise A, Montrey, Kathleen, Walsh, Kristy, Huntington, Scott F., Mato, Anthony, Landsburg, Daniel Jeffrey, Nasta, Sunita, Schuster, Stephen J.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Utility of FDG-PET/CT in lymphoma patients undergoing immunotherapy with autologous CTL019 T-cells
Shah, Nirav Niranjan, Torigian, Drew A., Farwell, Michael, Hwang, Wei-Ting, Frey, Noelle V., Nasta, Sunita, Landsburg, Daniel Jeffrey, Mato, Anthony R., June, Carl H., Schuster, Stephen J., Porter, David L., Svoboda, Jakub
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+ lymphomas
Schuster, Stephen J., Svoboda, Jakub, Nasta, Sunita, Porter, David L., Mato, Anthony, Shah, Gaurav D., Landsburg, Daniel Jeffrey, Chong, Elise A, Lacey, Simon F., Melenhorst, Jan J., Chew, Anne, Hasskarl, Jens, Shah, Nirav Niranjan, Wasik, Mariusz A., Marcucci, Katherine, Zheng, Zhaohui, Levine, Bruce, June, Carl H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article